The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Self-collection kits for HPV are among innovations adding momentum to eradication of cervical cancer
A kit for at-home unsupervised self-collection clears FDA finish line

Cancer Policy

FDA adds stereotactic breast biopsy needles to the shortage list

CMS proposed rule would implement electronic prior authorization requirements for covered drugs in federal health plans

At Friends meeting, data quality, modern evidence generation, and early regulatory alignment top the list of “next steps” for external control arms

ACIP charter is renewed as meetings remain on indefinite hold

FDA issues reminder to sponsors: Disclose clinical trial results

Health groups urge Bhattacharya, in his position of acting CDC director, to restore staff in the Office on Smoking and Health

Clinical Roundup

ATOMIC phase III trial establishes standard-of-care for patients with stage 3 dMMR colon cancer

Experimental drug doubles one-year survival in pancreatic cancer trial, Northwestern study finds

First in-human trial primes immune system to accept donor livers, UPMC study finds

DYV800 topical therapy targets tumor acidity, preclinical study finds

E-cigarette taxes reduce vaping; no increase in adult smoking, OSU study finds

Clinical trial aims to address vaginal complaints after breast cancer diagnosis

In The Clinic
Trials & Tribulations

Protecting the cure: Why the future of radiation oncology must be precision-guided

FreeTrials & Tribulations
Trials & Tribulations
FreeTrials & Tribulations
Latest Issue
Read the latest issue
Read the latest issue
DOWNLOAD THE PDF
UPCOMING EVENTS
May 2026
29
2026 ASCO Annual Meeting
Jun 2026
25
MASCC/ISOO 2026 Annual Meeting
View All Events

The Cancer Letter is an independent weekly news publication and the leading source for information on the issues that shape oncology.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account